JW Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

JW Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-22,559	Closed	-$3.17M	–	41
2015 Q4	$3.17M	Sell	22,559 -10,000	-31%	-$1.39M	1.18%	18
2015 Q3	$4.32M	Sell	32,559 -687	-2%	-$118K	1.57%	17
2015 Q2	$5.85M	Buy	33,246 +810	+2%	+$145K	1.78%	15
2015 Q1	$5.61M	Buy	32,436 +3,819	+13%	+$655K	2.42%	12
2014 Q4	$4.68M	Buy	+28,617	New	+$4.75M	3.52%	10

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JW Asset Management's JAZZ Position: Q1 2016 in Review

JW Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2016, closing a stake of 22,559 shares — an estimated $3.17M sold.

JW Asset Management first reported a position in JAZZ in Q4 2014 and held it in 5 quarters. The position peaked at $5.85M in Q2 2015. 339 funds tracked by Wall St. Rank hold JAZZ as of Q1 2016.

JW Asset Management reported no remaining Jazz Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
JW Asset Management sold 22,559 Jazz Pharmaceuticals shares in Q1 2016, an estimated $3.17M.
JW Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 5 quarters.
JW Asset Management's Jazz Pharmaceuticals position peaked at $5.85M in Q2 2015.
339 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2016.

Based on JW Asset Management's 13F filing for Q1 2016, filed 12 May 2016.